|
gptkbp:instance_of
|
gptkb:biotechnology
|
|
gptkbp:approves
|
gptkb:FDA
|
|
gptkbp:availability
|
in multiple countries
|
|
gptkbp:clinical_trial
|
conducted
supports use
|
|
gptkbp:cost_comparison
|
lower than Adalimumab
|
|
gptkbp:drug_interactions
|
similar to Adalimumab
|
|
gptkbp:formulation
|
may differ from Adalimumab
|
|
gptkbp:healthcare
|
improved
informed about options
potentially reduced
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Biosimilar to Adalimumab
|
|
gptkbp:interchangeability
|
may vary by product
|
|
gptkbp:invention
|
after Adalimumab
|
|
gptkbp:is_effective_against
|
similar to Adalimumab
|
|
gptkbp:manufacturer
|
multiple companies
|
|
gptkbp:market
|
required
|
|
gptkbp:market_authorization
|
granted by regulatory bodies
|
|
gptkbp:marketed_as
|
multiple names
|
|
gptkbp:pathway
|
abbreviated pathway
|
|
gptkbp:patient_education
|
necessary
|
|
gptkbp:patient_population
|
similar to Adalimumab
|
|
gptkbp:pharmacovigilance
|
important
|
|
gptkbp:provides_guidance_on
|
include recommendations
|
|
gptkbp:reference_drug
|
gptkb:Adalimumab
|
|
gptkbp:requires
|
available
|
|
gptkbp:research
|
ongoing
|
|
gptkbp:research_areas
|
immunology
|
|
gptkbp:route_of_administration
|
subcutaneous injection
|
|
gptkbp:safety_features
|
similar to Adalimumab
|
|
gptkbp:side_effect
|
similar to Adalimumab
|
|
gptkbp:storage
|
similar to Adalimumab
|
|
gptkbp:therapeutic_equivalence
|
assessed
|
|
gptkbp:treatment
|
monitored
|
|
gptkbp:type_of_insurance
|
may vary
|
|
gptkbp:used_for
|
gptkb:Crohn's_disease
gptkb:ulcerative_colitis
gptkb:rheumatoid_arthritis
psoriasis
|
|
gptkbp:bfsParent
|
gptkb:Merck_Biosimilars
|
|
gptkbp:bfsLayer
|
6
|